(MedPage Today) -- Mutations in ESR1 do not appear to confer breast cancer resistance to cyclin-dependent kinase (CDK)4/6 inhibitors, an analysis of clinical practice data suggested.
Tumor-resident microbiota in breast cancer promotes both the initiation and progression of cancer. However, the potential of targeting microbiota to enhance the efficacy of breast cancer treatment has not been comprehensively explored. In…
Get latest articles and stories on Health at LatestLY. Breast cancer survivors have a much greater chance of having secondary cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new…
Shutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive (ER+) breast cancer cells from growing after they acquired resistance to a standard therapy known as CDK4/6 inhibitors, UT Southwestern Medical Center…
Young-onset breast cancer (YOBC) with germline BRCA pathogenic variants (PVs) is associated with an increased risk for all-cause mortality if diagnosed within 10 years after childbirth, according to a study published online April 19 in…
Strictly Come Dancing professional Amy Dowden has been candid with fans about her treatment for breast cancer following her stage three diagnosis - from her shock symptom to celebrating her lastest milestone
The study calculated risks and found that women who survive breast cancer have double the risk of cancer in their other, healthy breast compared to the general population